Therapeutic Effects of Umbilical Cord Serum for Dry Eye Disease: A Systemic Review and Meta-Analysis
Ophthalmic Research · 02.12.2024 · 68 (1) · 71-83
DOI: 10.1159/000542731 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Ophthalmic Research, online erschienen am 02.12.2024. Verfasst von Bo Da Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Fetal Blood, Serum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Dry eye disease (DED) is a prevalent ocular condition that significantly impacts quality of life. Umbilical cord serum (UCS) has emerged as a promising therapeutic option, but its efficacy requires further investigation. This systemic review and meta-analysis aimed to evaluate the therapeutic effects of UCS eye drops in the treatment of DED.
Methods
A comprehensive literature search was conducted across multiple databases, including PubMed, Web of science, Embase, Science Direct, Cochrane Library, and China National Knowledge Network, to identify relevant clinical trials. The efficacy of UCS was assessed based on key outcome measures, such as the ocular surface disease index (OSDI), tear break-up time (TBUT), Schirmer I test, and corneal fluorescein staining scores. Meta-analyses were performed to pool the results, and the findings were presented in a forest plot.
Results
Eight studies were included in the meta-analysis, with two relevant randomized controlled trials (RCTs) involving a total of 204 patients. Most of the included studies had a follow-up time of less than 2 months. The pooled results showed that UCS treatment significantly improved the OSDI, with a mean difference (MD) of −9.16 (95% confidence interval [CI], −12.0, −6.36) compared to baseline. Additionally, the TBUT values were higher in the UCS group, with an MD of 2.65 (95% CI, 0.93, 4.36). The Schirmer I test results showed an improvement, with an MD of 1.18 (95% CI, 0.30, 2.06). The fluorescein staining score were also lower in the UCS treatment group, with an MD of −4.71 (95% CI, −5.72, −3.69).
Conclusion
This meta-analysis suggested that UCS eye drops had a beneficial therapeutic effect on DED, significantly improving the OSDI, TBUT, Schirmer I test, and corneal fluorescein staining scores. However, larger RCTs with longer follow-up periods were needed to further evaluate the long-term efficacy and safety of UCS in the management of DED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Ophthalmology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Zitieren
APA
Li, B. D., Jiang, J. X., Zhang, Q., Chu, Y. R., Chen, Z. Y., & Hu, K. (2024). Therapeutic Effects of Umbilical Cord Serum for Dry Eye Disease: A Systemic Review and Meta-Analysis. Ophthalmic Research, 68(1), 71-83. https://doi.org/10.1159/000542731
Vancouver
Li BD, Jiang JX, Zhang Q, Chu YR, Chen ZY, Hu K. Therapeutic Effects of Umbilical Cord Serum for Dry Eye Disease: A Systemic Review and Meta-Analysis. Ophthalmic Research. 2024;68(1):71-83. doi:10.1159/000542731
BibTeX
@article{Li2024,
author = {Li, Bo Da and Jiang, Jia Xuan and Zhang, Qi and Chu, Yi Ran and Chen, Ze Ying and Hu, Kai},
title = {Therapeutic Effects of Umbilical Cord Serum for Dry Eye Disease: A Systemic Review and Meta-Analysis},
journal = {Ophthalmic Research},
year = {2024},
volume = {68},
number = {1},
pages = {71--83},
doi = {10.1159/000542731}
}
EUVIMED